Bourbon virus infection screening

Revision as of 20:13, 13 September 2017 by Mmir (talk | contribs)
Jump to navigation Jump to search

Bourbon virus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bourbon virus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

CT

MRI

ECG

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bourbon virus infection screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bourbon virus infection screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bourbon virus infection screening

CDC on Bourbon virus infection screening

Bourbon virus infection screening in the news

Blogs on Bourbon virus infection screening

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency

Risk calculators and risk factors for Bourbon virus infection screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

According to CDC, there is insufficient evidence to recommend routine screening for Bourbon virus infection.[1]

Screening

According to CDC, there is insufficient evidence to recommend routine screening for Bourbon virus infection.[1]

References

  1. 1.0 1.1 "Bourbon virus | Division of Vector-Borne Diseases (DVBD) | NCEZID | CDC".

Template:WH Template:WS